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1947left atrial dilation. Indeed, if one performs a thought
experiment where the subvalvular apparatus is held
ﬁxed, but the annulus dilates, apical displacement of
the leaﬂets at systolic closure would be expected.
Another instance pointing to the potential role for
annular dilation is so-called atrial functional MR,
which may occur in the presence of persistent atrial
ﬁbrillation but in the absence of left ventricular
remodeling. On the other hand, papillary muscle dis-
placement may be particularly important in ischemic
disease (3). In an individual patient, both mechanisms
may contribute, and this may have practical signiﬁ-
cance. For instance, the MitraClip (Abbott Vascular,
Santa Clara, California) is the percutaneous equivalent
of the Alﬁeri edge-to-edge stitch, the latter of which
appears to more successfully treat secondary MR in
association with an undersized annuloplasty (4). It has
therefore been proposed that a percutaneous annulo-
plastymethod be used as an adjunct with theMitraClip
(5), if and when the former becomes available.*Chester M. Boltwood, Jr., MD
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Cardiothorac Surg 2011;39:807–8.REPLY: Secondary Mitral RegurgitationDrs. Boltwood and Shah focus on annular dilation as
the mechanism of apical tethering of the mitral valve
leaﬂets rather than papillary muscle displacement in
secondary mitral regurgitation (MR). In fact, annular
dilation has long been recognized as a cause of sec-
ondary MR in those with atrial ﬁbrillation and left
atrial dilation in the absence of left ventricular
dysfunction (Carpentier Type I) (1). In the setting ofleft ventricular dysfunction, however, it is generally
agreed that the major mechanism of MR in most cases
is systolic mitral valvular tenting as described by Yiu
et al. (2), due to both apical and posterior displacement
of the papillary muscles. Annular dilation is a sec-
ondary event that adds to MR severity. Although sur-
gical annuloplasty with an undersized complete rigid
ring initially completely corrects MR, MR may recur in
one-third of cases within 1 year due to ongoing left
ventricular remodeling with increased leaﬂet teth-
ering (3). Isolated treatment of annular dilation may
also fail to correct severe anterior leaﬂet tethering in
the case of apical displacement of the papillary mus-
cles (4). Finally, the MitraClip (Abbott Vascular, Santa
Clara, California) has proven to durably reduce MR in
both primary and secondary MR, even without an
annuloplasty (5). The mechanism in part is likely due
to stabilizing the septal lateral dimension of the mitral
annulus, similar to surgical annuloplasty. Further
study is required to determine whether transcatheter
annuloplasty offers equivalent long-term effective-
ness as the MitraClip for secondary MR, and whether
the combination of annuloplasty plus the MitraClip
provides incremental beneﬁt. If it does, it will most
likely be in those patients with the greatest degree of
annular dilation and leaﬂet tethering.Anita W. Asgar, MD
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